Effects of a single, daily alcoholic beverage on lipid and hemostatic markers of cardiovascular risk AMERICAN JOURNAL OF CARDIOLOGY McConnell, M. V., Vavouranakis, I., Wu, L. L., Vaughan, D. E., Ridker, P. M. 1997; 80 (9): 1226-?

Abstract

There is substantial epidemiologic data, but limited experimental data, supporting the mortality benefit of low-dose alcohol consumption. A regimen of a single, daily alcoholic beverage was sufficient to increase both high-density lipoprotein (HDL) (4.4%, p = 0.03) and HDL2 (7.7%, p = 0.04) in men and women, but did not significantly affect hemostatic markers of cardiovascular risk.

View details for Web of Science ID A1997YD11600024

View details for PubMedID 9359559